
Albert Bourla, chairman and CEO of Pfizer, has been awarded the 2022 Genesis Prize for his “leadership, determination and especially for his willingness to assume great risks” in developing a coronavirus vaccine in record time.
The Genesis Foundation recognises individuals for their contribution to humanity and commitment to Jewish values.